asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress
asia pacific pharmaceutical compliance congress



Overview | Agenda | Continuing Education | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel
Registration | Administration | Speaking Proposals | Webcast Log In | Contact Us | Past Events | Home





FIFTH ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS
AND BEST PRACTICES
FORUM


ATTEND ONSITE
August 17 - 18, 2015
Sofitel Philippine Plaza
Manila, Philippines
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months






CO CHAIRS

Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore

Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Shanghai, China

Maria "Maru" Quindimil, MBA
Executive Director, People Development, Business Practices Compliance and Risk Management Division, APAC Region, Pharsight, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines

Rhys Tee
Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore

KEYNOTE SPEAKERS

Robert Barrington, PhD
(via video)

Executive Director, Transparency International-UK, London, UK

Jean-Luc Lowinski, PhD
Senior Vice President, Asia Region, Sanofi, President, Sanofi China, Former Head, Bayer Healthcare, Asia Pacific, Shanghai, China

Theresa Martinez, MBA
General Manager, Roche Philippines, Inc., Manila, Philippines

Beaver R. Tamesis, MD
President and Managing Director, MSD in the Philippines, Manila, Philippines

Ashley Watson, Esq.
Senior Vice President, Chief Ethics & Compliance Officer, Merck Sharp and Dohme, Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA, USA

PHILIPPINE KEYNOTE SPEAKERS

Karen Alparce-Villanueva
Consultant, Philippine Alliance of Patient Organizations, Manila, Philippines

Dra Minerva Calimag, MD
President, Philippine Medical Association, Manila, Philippines

Fatima "Girlie" Garcia-Lorenzo
Executive Director, Philippine Alliance of Patient Organizations, Manila, Philippines

Reiner Gloor
President, Birgli AG, Advisor, Pharmaceutical & Healthcare Association of the Philippines, Former Executive Director, Pharmaceutical & Healthcare Association of the Philippines, Former Chairman, Buergli Pharma Inc., Manila, Philippines

Cynthia K. Magdaraog
President of Philippine Society of Orphan Disorders, Manila, Philippines

Teodoro (Ted) Padilla, MBA
Executive Director, Pharmaceutical & Healthcare Association of the Philippines (PHAP), Chief Executive Officer, PHAPCares Foundation, Manila, Philippines

OFFERED IN SEQUENCE WITH
APEC 2nd Business Ethics for Small & Medium Size Enterprises (SME) Forum
August 19 - 20, 2015

Including its pharma working group re APEC Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector, known as the "Mexico City Principles", and the medical device working group re the Nanjing Declaration to Promote Ethical Business Practices in the Medical Device and Biopharmaceutical Sectors (2014-2020), known as the "Nanjing Declaration".

For more information go
to www.MCPrinciples.org.

ROUNDTABLE ON HOT ASIA PAC PHARMA AND DEVICE COMPLIANCE ISSUES

Campbell Clark
General Counsel, Asia, Covidien, Singapore

Katsumi Kojima
Corporate Officer, Country Compliance Officer Japan, Sanofi, Former Director, Regional Compliance Officer APAC/JAPAN, Edwards Lifesciences, Tokyo, Japan

Cristopher Landrito, LIB
Regional Compliance Officer, APAC Group Compliance, Merck Pte. Ltd., Singapore

Redentor Romero, JD
Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel - Southeast Asia & Taiwan, AstraZeneca Pharmaceuticals, Singapore

Sandeep Seth
Director - Compliance, Merck & Co., Mumbai, India

Clarissa Shen
Country Compliance Officer, Sanofi China, Former Associate Compliance, Director, Eli Lilly China, Shanghai, China

GLOBAL ANTICORRUPTION UPDATE

Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)

Donemark Calimon, LLB
Partner, Quisumbing Torres, A member firm of Baker & McKenzie International, Manila, Philippines

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC, USA

Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief, Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA

Chen Yang, Esq.
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China

GLOBAL TRANSPARENCY UPDATE
Global Transparency Update

Diva DOUNG
Vice President Compliance EMEA-APAC, IMS Health, Paris, France
Australia Update

Andrew Ho
Country Compliance Officer, Australia and New Zealand, Compliance and Business Integrity, Sanofi Group; Former Compliance Associate, Novartis, Macquarie Park, NSW, Australia
Japan Voluntary Transparency
Guidelines Update

Yota Kikuchi
Manager, Compliance Japan, Sanofi Group; Vice Chairman, Code Practices, Committee, Japan Pharmaceutical Manufacturers Association; Member, IFPMA Code, Compliance Network, Tokyo, Japan
Research and Clinical
Trials Update

Jessica Santos, PhD, CIPP/E
Global Compliance Director, Kantar Health; Former Vice, President, Methodology and Compliance, WorldOne, Cambridge, UK

FEATURED FACULTY

Dimas Adityo, MA
Compliance Director, Sanofi, Jakarta Area, Indonesia

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA

Maija Burtmanis, LLB, LLM
Founder and Managing Director, Compliance Risk Logic, Former Regional Compliance Director, Asia, Australia, Africa, Middle East & Japan, AbbVie, Singapore

Chi Chen
Partner, Forensic Technology and Discovery Services, EY, Shanghai, China

Eugene Chen, Esq.
Partner, Shanghai Office, Hogan Lovells International LLP, Shanghai, China

Myung Soon Chung, Esq.
Partner, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea

Laurent Clerc
Co-founder and Regulatory Affairs Expert, BMI SYSTEM, Paris, France

Georgie Farrant, LLB
Partner, Baker & McKenzie, Sydney, Australia

Mohit Grover
Executive Director, Risk Consulting, Deloitte; a leader in the Life Science and Health Care Industry in Southeast Asia; Former Regional CIO, Astra Zeneca Asia Pacific, Singapore

Divina Ilas-Panganiban, LLM
Partner, Quisumbing Torres, A member firm of Baker & McKenzie International, Manila, Philippines

Marjotin Javellana
Director, Business Excellence & Alliance Management, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines

Angela Mancini
Director of Global Client Services, Southeast Asia, Control Risks

Maria Christina J. Macasaet-Acaban, LLB
Partner and Head, Pharmaceuticals & Healthcare Industry Group, Philippines, Member, Asia Pacific Pharmaceuticals & Healthcare Steering Committee, Baker & McKenzie, Manila, Philippines

Andrew Martin, SFE
Partner and Head, Corporate & Securities Practice Group in Singapore, Member, Global Compliance Steering Committee, Baker & McKenzie/Wong & Leow, Singapore

Chrisoula Nikidis
Director, Ethics and Compliance, Canada's Research-Based Pharmaceutical Companies (Rx&D), Ottawa, ON, Canada

Paul Peterson, CPA, CIA, CFE
Director, Grant Thornton China, Shanghai, China

Yee Chung Seck, LLB
Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam

Sabina Sudan, LLB, LLM
Senior Global Legal/Compliance & Risk Management Professional, Former Vice President and Compliance Officer- EJEMAP, GSK, Former Director- Compliance APAC, Abbott, Delhi, India

Belinda Tan
Partner, Fraud Investigation & Dispute Services, EY, Singapore

Roderick T. Vega
Partner, Fraud Investigation and Dispute Services, EY, Manila, Philippines

Emmanuel Vignal
Greater China Leader, Fraud Investigation & Dispute Services, EY, Shanghai, China

Wimbanu Widyatmoko, LLM
Partner, Hadiputranto, Hadinoto & Partners, A member firm of Baker & McKenzie International, Jakarta, Indonesia

Russell Williams
President, Canada's Research-Based Pharmaceutical Companies (Rx&D), Former Member, National Assembly of Quebec, Ottawa, ON, Canada

Michael Woodward
General Manager, Asia Pacific Region, The Red Flag Group, Hong Kong


EARLY BIRD REGISTRATION
- SAVE UP TO $600 -
Register by Friday, July 3, 2015 for Early Bird discount. Save up to $600.
Click here to register.

SPECIAL ASIA PACIFIC HEALTHCARE INDUSTRY COMPLIANCE TEAM/ PHAP/PAPO/APEC/ETHICS/IFPMA/PCF INDIVIDUAL RATE
Click here for special rates.
BROCHURE NOW AVAILABLE
Click here to download the brochure.
COSPONSORED BY:

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.



The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.



The Pharmaceutical and Healthcare Association of the Philippines (PHAP) and it's 56 member companies represent the research -based and pharmaceutical and healthcare industry, a key sector in the never ending fight for improved health through the continuous development of new , better, more efficacious and cost-effective drug therapies.



The Philippine Alliance of Patient Organizations (PAPO) is the umbrella organization of all the patient groups in the Philippines. It is an affiliate of the International Alliance of Patient Organizations.



The Philippine Medical Association is the primary medical association of the Philippines, covering medical practitioners and component medical groups from the entire country. It is a member of the World Medical Association and is a co-founder of the Confederation of Medical Associations of Asia and Oceania. It is also the co-founder of Medical Associations of South East Asian Nations.

GRANTORS:
BRONZE
















MEDIA PARTNER


TOPICS TO BE COVERED
  • Training on Compliance and Ethics Basics
  • Hot Asia Pac Compliance Issues Roundtable
  • Philippine Pharmaceutical and Medical Associations and Government Roundtable
  • Philippine Alliance of Patient Organizations Roundtable
  • Compliance and Ethics: Tone from the Top and Middle
  • A Global Chief Compliance OfficerÂ’s Perspective
  • Global Compliance Code and APEC Principles Updates
  • Global Anticorruption 2.0 Update
  • Transparency InternationalÂ’s new Pharma Industry Initiative
  • Global Transparency/Disclosure Update
  • Managing and Monitoring Mature Third Party Relationships
  • Risk Management for Compliance and Business
  • Medical Device Compliance Roundtable
  • Ethical Interactions with Patients
  • China Compliance Roundtable
  • Southeast Asia Compliance Roundtable
  • Responding to Investigations
  • Compliance Analytics Roundtable
  • Travel, Entertainment, Service Agreements and Honoraria
  • Samples, Grants, Donations and Social Media
  • Compliance Issues in M&A
CONTINUING EDUCATION CREDITS
  • Accounting Professionals: Approved for up to 14 NASBE CPE credits.
  • Compliance Professionals: The Congress is currently pending approval to offer Compliance Certification Board CCB Credits.
  • Attorneys: The Congress is currently pending approval to offer California and Pennsylvania MCLE Credit.
Click here for more information.

SAVE THE DATE
Mastering Compliance in International Markets
June 8 - 9, 2015 in Singapore
Click here for info.

OTHER PHARMA CONGRESS CITIES


2007 - Brussels, Belgium


2008 - Paris, France


2009 - Rome, Italy


2010 - Berlin, Germany


2011 - Istanbul, Turkey


2011 - Singapore


2012 - Budapest, Hungary


2012 - Shanghai, China


2012 - São Paulo, Brazil


2013 - Madrid, Spain


2013 - Kuala Lumpur, Malaysia


2014 - Dubai, United Arab Emirates


2014 - Mexico City, Mexico


2014 - Shanghai, China


2015 - Manila, Philippines




FIFTH ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS AND BEST PRACTICES FORUM

August 17 - 18, 2015

ATTEND ONSITE
Sofitel Philippine Plaza
Manila, Philippines


OR
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months


SAVE THE DATE

TENTH INTERNATIONAL PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 10 - 12, 2016
Warsaw, Poland
www.InternationalPharmaCongress.com
SIXTEENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
October 21 - 23, 2015
Mandarin Oriental
Washington, DC
www.PharmaCongress.com

PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction





We subscribe to the HONcode principles of the HON Foundation. Click to verify.




LIVE AND ARCHIVED WEBCAST ATTENDANCE
Watch the conference in live streaming video of plenary sessions and listen to audio of preconference and track sessions over the Internet and at your convenience at any time 24/7 for six months following the event.

The archived conference includes speaker Video and Audio and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for the next six months; accessible in the office, at home or anywhere worldwide with Internet access; avoid travel expense and hassle; no time away from the office.





WEBCAST INTERFACE SAMPLE

Click here for a sample stream


THE 2014 FOURTH ASIA PACIFIC PHARMA CONGRESS CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The 2014 Fourth Asia Pacific Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE ASIA PACIFIC PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of 2014 Fourth Asia Pacific Pharma Congress Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2014 Fourth Asia Pacific Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE ASIA PACIFIC PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).




Overview | Agenda | Continuing Education | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel
Registration | Administration | Speaking Proposals | Webcast Log In | Contact Us | Past Events | Home




© Health Care Conference Administrators
Contact Webmaster